Literature DB >> 26261614

Diagnostic value of progesterone receptor, p16, p53 and pHH3 expression in uterine atypical leiomyoma.

Yun Liang1, Xiaofei Zhang1, Xiaoduan Chen1, Weiguo Lü2.   

Abstract

The differential diagnosis between atypical leiomyoma and leiomyosarcoma may be hard based on morphological criterion at times. It would be helpful to find out biomarkers that can be used to distinguish them. The aim of the study was to investigate the diagnostic value of progesterone receptor (PR), p16, p53 and pHH3 expression in a series of uterine smooth muscle tumors. Immunohistochemical expression of PR, p16, p53 and pHH3 was investigated on 32 atypical leiomyomas, 15 leiomyosarcomas and 15 usual leomyomas. The difference in expression was compared between atypical leiomyoma and other groups. The expression of PR, p16, and pHH3 was found significantly different between atypical leiomyomas and leiomyosarcomas, but lack of significant difference between atypical leiomyomas and usual leiomyomas. There was no significant difference with regard to p53 distribution among these uterine smooth muscle tumors. High p16, pHH3 expression and low PR expression preferred the diagnosis of leiomyosarcoma. The panel of antibodies used in this study is a useful complementary analysis in the assessment of problematic uterine smooth muscle tumors.

Entities:  

Keywords:  Atypical leiomyoma; PR; immunohistochemistry; p16; p53; pHH3

Mesh:

Substances:

Year:  2015        PMID: 26261614      PMCID: PMC4525948     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

Review 1.  p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia.

Authors:  Alexandra N Kalof; Kumarasen Cooper
Journal:  Adv Anat Pathol       Date:  2006-07       Impact factor: 3.875

2.  Immunohistochemical analysis in the diagnosis of uterine myometrial smooth muscle tumors.

Authors:  Anca Daniela Stănescu; Elena Nistor; Maria Sajin; Alex Emilian Stepan
Journal:  Rom J Morphol Embryol       Date:  2014       Impact factor: 1.033

3.  Differential Immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants.

Authors:  Brian R Gannon; Marosh Manduch; Timothy J Childs
Journal:  Int J Gynecol Pathol       Date:  2008-01       Impact factor: 2.762

4.  Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.

Authors:  S W Bell; R L Kempson; M R Hendrickson
Journal:  Am J Surg Pathol       Date:  1994-06       Impact factor: 6.394

5.  The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors.

Authors:  Kristen A Atkins; Nora Arronte; Christopher J Darus; Laurel W Rice
Journal:  Am J Surg Pathol       Date:  2008-01       Impact factor: 6.394

6.  Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors.

Authors:  Longwen Chen; Bin Yang
Journal:  Int J Gynecol Pathol       Date:  2008-07       Impact factor: 2.762

7.  Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors.

Authors:  Hüsnü Gökaslan; Levent Türkeri; Zehra Neşe Kavak; Funda Eren; Alper Sişmanoğlu; Sennur Ilvan; Fatih Durmuşoğlu
Journal:  Gynecol Obstet Invest       Date:  2004-09-20       Impact factor: 2.031

8.  A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors.

Authors:  Cheng-Han Lee; Dmitry A Turbin; Y-C Vanessa Sung; Inigo Espinosa; Kelli Montgomery; Matt van de Rijn; C Blake Gilks
Journal:  Mod Pathol       Date:  2009-09-04       Impact factor: 7.842

9.  Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study.

Authors:  Emanuela Veras; Anais Malpica; Michael T Deavers; Elvio G Silva
Journal:  Int J Gynecol Pathol       Date:  2009-07       Impact factor: 2.762

10.  Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.

Authors:  C J O'Neill; H A McBride; L E Connolly; W G McCluggage
Journal:  Histopathology       Date:  2007-06       Impact factor: 5.087

View more
  3 in total

1.  Morphological and Ancillary Features of Uterine Leiomyosarcoma: Case Report.

Authors:  Mădălina Boșoteanu; Raluca Ioana Vodă; Mariana Așchie; Luana-Andreea Bosoteanu; Gabriela Izabela Bălțătescu
Journal:  Clin Pathol       Date:  2022-06-27

2.  Expression and prognostic value of lactate dehydrogenase-A and -D subunits in human uterine myoma and uterine sarcoma.

Authors:  Ke-Juan Song; Xiao-Ni Yu; Teng Lv; Yu-Long Chen; Yu-Chao Diao; Su-Li Liu; Yan-Kui Wang; Qin Yao
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

Review 3.  The Usefulness of Immunohistochemistry in the Differential Diagnosis of Lesions Originating from the Myometrium.

Authors:  Piotr Rubisz; Michał Ciebiera; Lidia Hirnle; Magdalena Zgliczyńska; Tomasz Łoziński; Piotr Dzięgiel; Christopher Kobierzycki
Journal:  Int J Mol Sci       Date:  2019-03-06       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.